Brian M. Silver - Jul 15, 2021 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Signature
/s/ Brian M. Silver
Stock symbol
TCRX
Transactions as of
Jul 15, 2021
Transactions value $
$0
Form type
4
Date filed
7/16/2021, 04:40 PM
Next filing
Sep 13, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRX Stock Option (right to buy) Award $0 +250K $0.00 250K Jul 15, 2021 Voting Common Stock 250K $15.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option will vest with respect to 25% of the shares after 12 months of continuous service to the Issuer following May 3, 2021, and the balance will vest in equal monthly installments over the next 36 months of continuous service to the issuer. If Mr. Silver's employment is terminated without cause or for good reason within the three months prior to a change of control or within 12 months at or following a change of control, any unvested shares or equity awards shall immediately vest.